retatrutide clinical CutKilo | Retatrutide: Phase 3 Results, Uses
Description
Pazarci, P
If youre experiencing GLP-1 nausea, try sticking to bland foods for a short period of time while your body adjusts
Factors such as previous eye problems, cardiovascular disease, and use of other medications known to increase NAION risk (like PDE5 inhibitors) should be carefully evaluated before starting GLP-1 therapy
Companies developing once-weekly or once-monthly formulations with superior weight loss and cardiovascular benefits will capture premium market segments and drive market expansion
